Philips Recalls Some Masks Used With Respiratory Devices Over Potential Injury Risk
The FDA said Koninklijke Philips NV (NYSE:PHG) recalled certain masks used with some of its respiratory machines due to the potential risk…
Walmart And UnitedHealth Announce 10-Year Collaboration, Which Will Include A Co-Branded Medicare Advantage Plan In Georgia; Walmart Health Virtual Care To Also Be In Network For Commercial Members In UnitedHealthcare’s Choice Plus PPO Plan
Select Walmart Health locations will help improve health outcomes for people by advancing value-based care, powered by proven Optum clinical capabilities
Collaboration will grow to include additional products and
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
Equillium Inc (NASDAQ:EQ) has agreed to acquire Metacrine Inc (NASDAQ:MTCR) in an all-stock transaction. The transaction is anticipated to add $33 million…
Rhythm Secures European Commission Marketing Authorization For Genetic Disease Candidate
The European Commission (EC) has expanded the marketing authorization for Rhythm’s (NASDAQ: RYTM) lead drug product IMCIVREE (setmelanotide) to include the treatment of obesity and control of hunger associated with genetically confirmed Bardet-Biedl syndrome (BBS) in adult and pediatric patients 6 years of age an
Vaxcyte Completes Enrolment In Mid-Stage Pneumococcal Disease Study, Sees Top-line Data In H1 2013
Vaxcyte (NASDAQ: PCVX) has completed patient enrollment in the Phase 2 study evaluating VAX-24 in healthy adults 65 years of age and older.
VAX-24 is its lead, 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD).
Eledon Shares Climb After Securing FDA Nod For Mid-Stage Kidney Disease Study
Eledon Pharmaceuticals (NASDAQ: ELDN) received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to evaluate tegoprubart for the treatment of IgA Nephropathy (IgAN).
This Analyst Sees Recovery For PolyPid Despite Failed Phase 3 Readout
Raymond James downgraded PolyPid Ltd (NASDAQ:PYPD) from Strong Buy to Outperform post SHIELD I Phase 3 results that, despite consistency and evidence of…
Athira Outlines Possible Comeback For Alzheimer’s Candidate
Athira Pharma Inc (NASDAQ:ATHA) announced an update to its plans for the ongoing LIFT-AD trial of fosgonimeton (ATH-1017) for mild-to-moderate Alzheimer’s…
FDA Again Highlights Lacking Data From Amylyx’s Amyotrophic Lateral Sclerosis Candidate
The FDA released briefing documents for Amylyx Pharmaceuticals Inc’s (NASDAQ:AMLX) experimental amyotrophic lateral sclerosis drug, as a second adcomm is scheduled…
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
The European Union’s drugs regulator is just a few weeks away from deciding whether to approve Sanofi SA (NASDAQ:SNY) and GSK…